๐ข Recruiting
Early Phase 1
๐ Investigational Drug / Biologic
NCT07428707
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
View Study & Checklist โ